Dermata Therapeutics EPS DRMA

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Dermata Therapeutics' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was −$0.74.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.74	n/a	n/a
Q1 FY26	Mar 31, 2026	−$0.48	n/a	n/a
Q3 FY25	Sep 30, 2025	−$1.65	n/a	n/a
Q2 FY25	Jun 30, 2025	−$1.66	n/a	n/a
Q1 FY25	Mar 31, 2025	−$4.47	n/a	n/a
Q3 FY24	Sep 30, 2024	−$20.41	n/a	−$200.33
Q2 FY24	Jun 30, 2024	−$41.82	n/a	−$260.92
Q1 FY24	Mar 31, 2024	−$70.60	n/a	n/a
Q4 FY23	Dec 31, 2023	−$67.50	n/a	n/a
Q3 FY23	Sep 30, 2023	−$81.00	n/a	n/a
Q1 FY23	Mar 31, 2023	−$340.50	n/a	−$1725.00
Q4 FY22	Dec 31, 2022	−$325.50	n/a	−$2187.00

Companies in Healthcare nearest Dermata Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
DRMADermata Therapeutics	n/m
OXBROXBRIDGE RE HOLDINGS	$0.02
EDUCEducational Development	$0.19
GTIMGood Times Restaurants	$0.21	+75% a year
MDRRMedalist Diversified	$3.84
BCGBinah Capital	$0.16
VIPVulcan Infrastructure & Power	$0.07
MXCMexco Energy	$0.75	−5% a year
CKXCKX Lands	$1.42	+647% a year
MSGMMotorsport Games	$0.43	+187% a year
ATCHAtlasClear	$0.01
Peer median	$0.20